Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

85.49
Delayed Data
As of Jan 19
 -0.33 / -0.38%
Today’s Change
74.00
Today|||52-Week Range
89.09
+1.22%
Year-to-Date
Oakbrook Investments Llc Buys Apple Inc, Starbucks Corp, Boeing Co, Sells General Ele...
Jan 18 / GuruFocus News - Paid Partner Content
Merck's Keytruda on a Roll: Can it Retain the Spark in 2018?
Jan 12 / Zacks.com - Paid Partner Content
Merck Strong on Confirmatory Phase III Lung Cancer Study
Jan 17 / Zacks.com - Paid Partner Content
Big Pharma CEOs Speak About Impact of Tax Reform on M&A
Jan 11 / Zacks.com - Paid Partner Content
A Rally in Eli Lilly Could Heal Traders, Investors
Jan 17 / TheStreet.com - Paid Partner Content
FDA Approvals Surge in 2017: Here's a Look at the Numbers
Jan 09 / Zacks.com - Paid Partner Content
Nektar Boasts Strong Pipeline, Competition Remains a Woe
Jan 17 / Zacks.com - Paid Partner Content
Pfizer to Stall R&D for Alzheimer's/Parkinson's, Cut Jobs
Jan 08 / Zacks.com - Paid Partner Content
Dow 30 Stock Roundup: Boeing Q4 Deliveries Up Y/Y, Success for Merck's Keytruda Combo
Jan 12 / Zacks.com - Paid Partner Content
Alzheimer's takes Another Hit as Pfizer Ends Research in this Area
Jan 08 / Zacks.com - Paid Partner Content
Lilly's Elanco/Aratana's Veterinary Medicine Gets EU Nod
Jan 12 / Zacks.com - Paid Partner Content